Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Enhanced brain delivery of lamotrigine with Pluronic® P123-based nanocarrier

Authors Liu J, Wang J, Zhou J, Tang X, Xu L, Shen T, Wu X, Hong Z

Received 11 February 2014

Accepted for publication 17 April 2014

Published 16 August 2014 Volume 2014:9(1) Pages 3923—3935


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Jian-Sheng Liu,1,* Jian-Hong Wang,1,* Jie Zhou,2 Xing-Hua Tang,1 Lan Xu,1 Teng Shen,2 Xun-Yi Wu,1 Zhen Hong1

1Department of Neurology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, People’s Republic of China

*These authors contributed equally to this work

Background: P-glycoprotein (P-gp) mediated drug efflux across the blood­–brain barrier (BBB) is an important mechanism underlying poor brain penetration of certain antiepileptic drugs (AEDs). Nanomaterials, as drug carriers, can overcome P-gp activity and improve the targeted delivery of AEDs. However, their applications in the delivery of AEDs have not been adequately investigated. The objective of this study was to develop a nano-scale delivery system to improve the solubility and brain penetration of the antiepileptic drug lamotrigine (LTG).
Methods: LTG-loaded Pluronic® P123 (P123) polymeric micelles (P123/LTG) were prepared by thin-film hydration, and brain penetration capability of the nanocarrier was evaluated.
Results: The mean encapsulating efficiency for the optimized formulation was 98.07%; drug-loading was 5.63%, and particle size was 18.73 nm. The solubility of LTG in P123/LTG can increase to 2.17 mg/ml, making it available as a solution. The in vitro release of LTG from P123/LTG presented a sustained-release property. Compared with free LTG, the LTG-incorporated micelles accumulated more in the brain at 0.5, 1, and 4 hours after intravenous administration in rats. Pretreatment with systemic verapamil increased the rapid brain penetration of free LTG but not P123/LTG. Incorporating another P-gp substrate (Rhodamine 123) into P123 micelles also showed higher efficiency in penetrating the BBB in vitro and in vivo.
Conclusion: These results indicated that P123 micelles have the potential to overcome the activity of P-gp expressed on the BBB and therefore show potential for the targeted delivery of AEDs. Future studies are necessary to further evaluate the appropriateness of the nanocarrier to enhance the efficacy of AEDs.

Keywords: antiepileptic drug, lamotrigine, polymeric micelles, P-glycoprotein, pluronic, nanocarrier

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions

Almer G, Summers KL, Scheicher B, Kellner J, Stelzer I, Leitinger G, Gries A, Prassl R, Zimmer A, Mangge H

International Journal of Nanomedicine 2014, 9:4211-4222

Published Date: 3 September 2014

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents

Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS

International Journal of Nanomedicine 2014, 9:4117-4133

Published Date: 27 August 2014

Facile and green fabrication of electrospun poly(vinyl alcohol) nanofibrous mats doped with narrowly dispersed silver nanoparticles

Lin S, Wang RZ, Yi Y, Wang Z, Hao LM, Wu JH, Hu GH, He H

International Journal of Nanomedicine 2014, 9:3937-3947

Published Date: 18 August 2014

Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy

Liu L, Liu X, Xu Q, Wu P, Zuo X, Zhang J, Deng H, Wu Z, Ji A

International Journal of Nanomedicine 2014, 9:3509-3526

Published Date: 29 July 2014

Antibacterial properties of silver nanoparticles synthesized using Pulicaria glutinosa plant extract as a green bioreductant

Khan M, Khan ST, Khan M, Adil SF, Musarrat J, Al-Khedhairy AA, Al-Warthan A, Siddiqui MRH, Alkhathlan HZ

International Journal of Nanomedicine 2014, 9:3551-3565

Published Date: 28 July 2014

Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes

Perez AP, Casasco A, Schilrreff P, Defain Tesoriero MV, Duempelmann L, Altube MJ, Higa L, Morilla MJ, Petray P, Romero EL

International Journal of Nanomedicine 2014, 9:3335-3345

Published Date: 10 July 2014

Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016)

Ueno T, Endo K, Hori K, Ozaki N, Tsuji A, Kondo S, Wakisaka N, Murono S, Kataoka K, Kato Y, Yoshizaki T

International Journal of Nanomedicine 2014, 9:3005-3012

Published Date: 19 June 2014

Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy

Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, Singh AP

International Journal of Nanomedicine 2014, 9:2933-2942

Published Date: 18 June 2014